Skip to content
10-Q

Quarterly Report

DUSA PHARMACEUTICALS INC

0001193125-12-217834

← back to feed
Filed
May 8, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · May 4, 2012 24.93M sh
Capex Q1 2012 · Mar 31, 2012 $182.77K
Capex Q1 2012 · Mar 31, 2011 $75.61K
Operating Cash Flow Q1 2012 · Mar 31, 2012 $1.22M
Operating Cash Flow Q1 2012 · Mar 31, 2011 $1.58M
Cash And Equivalents Q1 2012 · Mar 31, 2012 $25.24M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $24.42M
Cash And Equivalents Q1 2012 · Mar 31, 2011 $12.47M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $8.88M
Stockholders Equity Q1 2012 · Mar 31, 2012 $28.16M
Stockholders Equity Q1 2012 · Dec 31, 2011 $28.28M
Current Liabilities Q1 2012 · Mar 31, 2012 $5.57M
Current Liabilities Q1 2012 · Dec 31, 2011 $6.47M
Total Liabilities Q1 2012 · Mar 31, 2012 $10.76M
Total Liabilities Q1 2012 · Dec 31, 2011 $9.74M
Current Assets Q1 2012 · Mar 31, 2012 $36.82M
Current Assets Q1 2012 · Dec 31, 2011 $36.19M
Total Assets Q1 2012 · Mar 31, 2012 $38.92M
Total Assets Q1 2012 · Dec 31, 2011 $38.02M
Sga Expense Q1 2012 · Mar 31, 2012 $3.08M
Sga Expense Q1 2012 · Mar 31, 2011 $2.45M
Rd Expense Q1 2012 · Mar 31, 2012 $2.05M
Rd Expense Q1 2012 · Mar 31, 2011 $1.32M
Net Income Q1 2012 · Mar 31, 2012 −$337.12K
Net Income Q1 2012 · Mar 31, 2011 −$604.9K
Operating Income Q1 2012 · Mar 31, 2012 $1.58M
Operating Income Q1 2012 · Mar 31, 2011 $1.6M
Gross Profit Q1 2012 · Mar 31, 2012 $11.35M
Gross Profit Q1 2012 · Mar 31, 2011 $9.35M
Cost Of Revenue Q1 2012 · Mar 31, 2012 $2.07M
Cost Of Revenue Q1 2012 · Mar 31, 2011 $1.63M